Science In Service.
Informing Ontario’s response to COVID-19
SCIENCE BRIEFS
A collective lens into emerging scientific evidence.
-
Paxlovid for a Patient on a DOAC
May 11, 2022
-
The COVID-19 Pandemic’s Impact on Long-Term Care Homes: Five Lessons Learned
April 28, 2022
-
Therapeutic Management of Residents of Long-term Care Homes with COVID-19
April 22, 2022
-
Update on COVID-19 Projections
April 14, 2022
-
Increased Screen Time for Children and Youth During the COVID-19 Pandemic
April 12, 2022
-
Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19
April 1, 2022
-
Update on COVID-19 Projections
March 17, 2022
-
Evidence-Based Recommendations on the Use of Nirmatrelvir/Ritonavir (Paxlovid) for Adults in Ontario
February 23, 2022